Professional Documents
Culture Documents
Apneic Sleep, Insufficient Sleep and Hypertension
Apneic Sleep, Insufficient Sleep and Hypertension
Apneic Sleep, Insufficient Sleep and Hypertension
and Hypertension
[Meghna P. Mansukhani, Naima Covassin,
Virend K. Somers]
Dr Femi A.M.
07/10/2023 1
INTRODUCTION
NORMAL SLEEP AND BLOOD PRESSURE(BP)
SLEEP-RELATED BREATHING DISORDERS AND HYPERTENSION(HTN)
MECHANISMS LINKING SLEEP APNEA AND HTN
OBSTRUCTIVE SLEEP APNOEA(OSA) AND SYSTEMIC HTN
INSUFFICIENT SLEEP, INSOMNIA, AND HTN
CONCLUSIONS
REFERENCES
07/10/2023 2
INTRODUCTION
OSA is the most common sleep-related breathing disorder, characterized by
repeated complete or partial upper airway inspiratory closure in sleep.
Like OSA, Short sleep duration has been strongly associated with HTN by
recent studies via some shared mechanisms such as sympathetic activation.
07/10/2023 3
INTRODUCTION
The article describes the normal physiology of BP in sleep and the literature
examining elevated BP in subjects with sleep-related breathing disorders
and insufficient sleep.
Hence, ventilation decreases to levels even lower than that seen during NREM
sleep, and Paco2 levels start to rise.
07/10/2023 6
NORMAL SLEEP AND BP
WAKEFULNESS:
Sudden increases in minute ventilation, HR, and BP are noted during arousals
and awakening.
07/10/2023 7
SLEEP-RELATED BREATHING DISORDERS AND HTN
some other cohorts showed higher prevalence rates(eg, 50% of men and 23%
of women in a population-based study in Switzerland).
07/10/2023 8
MECHANISMS LINKING SLEEP APNEA AND HTN
Chemoreflexes:
Recurrent episodes of sleep apnea lead to enhanced chemoreflex-mediated sympathetic
activation, result in increase in CO and sudden rise in BP that can be attenuated by CPAP.
These sudden increases in BP may be responsible for the nondipping pattern of BP seen
in subjects with untreated OSA.
Additionally, in subjects with OSA, repeated arousals from sleep especially in those with
persistent daytime sleepiness may contribute to persistent sympathetic overactivity and
07/10/2023 9
to the development of HTN over time
07/10/2023 10
MECHANISMS LINKING SLEEP APNEA AND
HTN
Baroreflex:
Blunted baroreceptor sensitivity in OSA subjects impairs acute autonomic
response to disordered breathing.
07/10/2023 11
MECHANISMS LINKING SLEEP APNEA AND HTN
Central Control:
An increase in the central neural response to chronic intermittent hypoxia
may contribute to the exaggerated acute sympathetic activity in OSA.
07/10/2023 12
MECHANISMS LINKING SLEEP APNEA AND HTN
Cardiovascular Variability:
Autonomic dysfunction in OSA subjects results in increased variability in BP;
impaired HR regulation and heightened vasomotor tone leads to hypertension.
Vascular Mechanisms:
Nighttime increases in endothelin release, endothelial cell dysfunction, and
apoptosis are seen in OSA, reversible with CPAP.
07/10/2023 13
MECHANISMS LINKING SLEEP APNEA AND HTN
Renin-Angiotensin-Aldosterone System:
Sympathetic activation results in the release of renin in the kidney, which leads to
increased production of Angiotensin II.
This in turn increases sympathetic tone by acting through central and peripheral
mechanisms and can lead to the development of hypertension.
Plasma aldosterone concentration and 24-hour urine aldosterone levels were found
to positively correlate with the apnea-hypopnea index in studies.
Aortic Stiffness:
A marker of adverse cardiovascular outcomes, including HTN, has been associated with
OSA and sleep deprivation, and may play a role in the development of HTN.
Hypothalamus-Pituitary-Adrenal Axis:
Activation leads to an increase in vasopressin-induced increased BP. Sleep deprivation
are associated with higher serum cortisol levels that can also increase BP.
Other Factors:
Increased Oxidative stress, inflammation, disordered breathing events and impairment
of exercise tolerance may be a contributory factor to hypertension or other adverse
cardiovascular outcomes in subjects with OSA and must be further studied.
07/10/2023 15
OBSTRUCTIVE SLEEP APNOEA(OSA) AND SYSTEMIC
HTN
OSA is seen in about 50% of those with HTN; 50% with HTN have comorbid OSA
which may be partially explained by shared risk factors eg obesity.
REM-related OSA has also been shown to be significantly associated with HTN
after accounting for confounders
There has been strong association between HTN and OSA severity in those
with excessive daytime sleepiness(they have more severe nocturnal
07/10/2023 16
desaturation and higher diastolic BP)
OBSTRUCTIVE SLEEP APNOEA(OSA)
AND SYSTEMIC HTN
OSA and Nondipping Pattern of BP:
Nondipping of BP is a -ve prognostic indicator associated with increased
cardiovascular morbidity, LVH and microalbuminuria; contribute to the
adverse cardiovascular outcomes seen in subjects with OSA.
07/10/2023 17
OBSTRUCTIVE SLEEP APNOEA(OSA)
AND SYSTEMIC HTN
OSA and Resistant HTN:
OSA is a common cause of resistant HTN and refractory HTN seen in approx.
70% of those with resistant HTN. The JNC 7 listed OSA as one of the
secondary causes of HTN.
07/10/2023 18
OBSTRUCTIVE SLEEP APNOEA(OSA)
AND SYSTEMIC HTN
Effects of Treatment of Sleep Apnea on Hypertension:
CPAP has been shown to decrease sympathetic activity and BP in sleep
especially in those with severe OSA and coexisting DM.
07/10/2023 19
OBSTRUCTIVE SLEEP APNOEA(OSA)
AND SYSTEMIC HTN
Effects of Treatment of Sleep Apnea on Hypertension:
Recent meta-analyses have shown a reduction of 5 to 7 mm Hg in systolic BP
and 3 to 6 mm Hg in diastolic BP with the use of CPAP in subjects with OSA and
resistant HTN.
The recent SAVE trial (Sleep Apnea Cardiovascular Endpoints) did not show a
beneficial effect of CPAP on major adverse cardiovascular events in subjects
with existing cardiovascular disease.
While excessive sleep duration may be similarly harmful, the impact of long sleep
for future HTN is generally weaker.
Studies have shown that associations between short sleep and elevated BP features
a demographic pattern, with greater vulnerability seen in women; younger and
middle-aged; blacks individuals
07/10/2023 22
INSUFFICIENT SLEEP, INSOMNIA, AND HTN
Insomnia:
The most frequent sleep disturbance; Sporadic insomnia symptoms are reported by
about 30% of the general population, and 6% to 10% for chronic insomnia disorder.
Prevalence of HTN was found to be higher in those with insomnia than in those
without insomnia (14.9%–43.1% versus 12.8%–18.7%).
Vgontzas et al found that odds ratios for HTN were 5-fold higher in insomniacs
sleeping <5Hrs than in normal sleepers.
07/10/2023 23
INSUFFICIENT SLEEP, INSOMNIA, AND HTN
Insomnia:
Mechanisms mediating HTN risk in insomnia include: abnormal neural circulatory
control; attenuated baroreflex sensitivity; increased sympathetic neural
cardiovascular reactivity to stress and enhanced hypothalamus-pituitary-
adrenal axis activity.
Relative to day workers, those working alternative shifts have been found to
be more likely to have high BP and exhibit aberrant 24-hour BP pattern and
dampened dipping during sleep.
07/10/2023 25
INSUFFICIENT SLEEP, INSOMNIA, AND
HTN
Shift Work:
Sympathetic cardiac predominance, increased inflammation, sleep
deficiency, augmented insulin and glucose levels are possible mechanisms.
07/10/2023 26
CONCLUSIONS
Fluctuations in autonomic activity occur during stages of normal physiologic sleep; alterations in
these events from disrupted sleep has been strongly linked with HTN.
Sleep disorders like OSA and insomnia have strong associations with HTN.
OSA is associated with BP in a dose-response fashion, and treatment of OSA results modest reduction
in 24-hour BP in those with HTN.
OSA is associated with nondipping of BP at night and is one of the most common causes of resistant
HTN; treatment of OSA may reverse nondipping and facilitate BP control in resistant HTN.
CPAP treatment of OSA lower BP especially in those with excessive daytime sleepiness.
Normalization of sleep times and optimization of sleep quality may yield significant benefits
The widespread prevalence of insufficient sleep and insomnia, along with their consequences in
terms of heightened hypertension risk, justifies the urgency of developing
07/10/2023
and implementing
27